Piotroski F-Score Stock Screen — Germany
Joseph Piotroski's F-Score gives a company one point for each of nine signs of improving financial health: profits, cash flow, falling debt, better margins and asset turnover, and no new shares issued. This screen keeps companies scoring 8 or 9 that also trade at a modest price-to-book, the cheap end of the market Piotroski studied.
The rules of this screen
A stock listed in Germany appears below only if it passes every rule:
- Price-to-book of 1.5 or less (share price at most 1.5x book value per share)
- Piotroski F-Score of 8 or more (out of 9)
- Market cap of at least €50 million
Data comes from company filings and market prices, refreshed after every trading day. Stocks with a missing value for any rule are left out.
Piotroski F-Score Stock Screen — Germany: top stocks by market cap
16 German stocks match this screen. All 16 by market cap, data as of 13 Nov 2026.
| # | Company | Ticker | Sector | Mkt Cap | P/E | Div Yield | 1Y |
|---|---|---|---|---|---|---|---|
| 1 | Fresenius SE & Co. KGaA | FREXETRA | Healthcare | €30.2B | 18.8 | 1.99% | +9.7% |
| 2 | Carl Zeiss Meditec AG | AFXXETRA | Healthcare | €3.1B | 25.2 | 1.60% | -15.8% |
| 3 | Drägerwerk AG & Co. KGaA | DRW3XETRA | Healthcare | €2.1B | 12.3 | 2.07% | +64.9% |
| 4 | Drägerwerk AG & Co. KGaA | DRW8XETRA | Healthcare | €1.6B | 9.4 | 2.68% | +41.3% |
| 5 | Dürr Aktiengesellschaft | DUEXETRA | Industrials | €1.1B | — | 4.93% | -17.4% |
| 6 | MBB SE | MBBXETRA | Industrials | €1.0B | 18.1 | 0.58% | +6.1% |
| 7 | RHÖN-KLINIKUM Aktiengesellschaft | RHKXETRA | Healthcare | €970.6M | 22.7 | 1.37% | +20.8% |
| 8 | Uzin Utz SE | UZUXETRA | Basic Materials | €346.0M | 12.6 | 2.91% | -6.0% |
| 9 | Ernst Russ AG | ERAGXETRA | Industrials | €302.5M | 5.1 | 2.79% | +33.2% |
| 10 | Medios AG | ILM1XETRA | Healthcare | €277.5M | 24.2 | 0.00% | -14.2% |
| 11 | MEDICLIN Aktiengesellschaft | MEDXETRA | Healthcare | €261.3M | 8.3 | 0.74% | +60.8% |
| 12 | Allgeier SE | AEINXETRA | Technology | €152.5M | 33.3 | 7.22% | -19.2% |
| 13 | Grammer AG | GMMXETRA | Consumer Cyclical | €117.8M | 6.2 | 0.00% | +26.4% |
| 14 | Blue Cap AG | B7EXETRA | Financial Services | €65.9M | — | 4.41% | -25.8% |
| 15 | q.beyond AG | QBY0XETRA | Technology | €62.8M | — | 0.00% | -45.9% |
| 16 | DocCheck AG | AJ91XETRA | Healthcare | €52.8M | 11.3 | 9.62% | -14.8% |
The same rules on every market the screener covers: the US, Canada, Europe, Australia and more. Free, no account needed.
Run this screen on all 18,000+ stocksHow to use this screen
The score compares the last two fiscal years, so it can be up to a year old, and it says nothing about price beyond the book-value test. A high score in a cyclical business near the top of its cycle can be misleading.
This page lists the stocks that pass a set of rules. It is not a recommendation to buy or sell any of them, and past results of a strategy say nothing certain about future returns.